Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Giapreza

Drug Giapreza

NDC 68547-501-02

Open in the dashboard

General payments

$560,663

2,039 payments

Research payments

$0

0 payments

Through program year 2019, $560,663 in general payments and $0 in research payments were reported against Giapreza (Giapreza).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $560,663 2,039

Breakdown

Who paid General payments · program year 2019
  1. La Jolla Pharmaceutical Company $560,663 2,039 payments
Top recipients General payments · program year 2019
  1. Ara Klijian Thoracic Surgery (Cardiothoracic Vascular Surgery) · Murrieta, CA $162,693 29% · 151 payments
  2. Childrens Hosp & Res Cntr Oakland Teaching hospital · CA $69,249 12% · 5 payments
  3. Harold Szerlip Nephrology · Charleston, SC $30,547 5% · 40 payments
  4. Jonathan Chow Critical Care Medicine · Washington, DC $21,865 4% · 41 payments
  5. Samir Awad Surgical Critical Care · Houston, TX $18,565 3% · 20 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Thoracic Surgery (Cardiothoracic Vascular Surgery) $173,725 38% · 66 practitioners
  2. Nephrology Internal Medicine $43,069 9% · 71 practitioners
  3. Critical Care Medicine Internal Medicine $39,432 9% · 102 practitioners
  4. Critical Care Medicine Anesthesiology $36,873 8% · 16 practitioners
  5. Anesthesiology $35,630 8% · 180 practitioners

The top 5 of 58 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $275,614 49% · 159 recipients
  2. Texas $65,353 12% · 74 recipients
  3. Florida $37,223 7% · 89 recipients
  4. District of Columbia $26,673 5% · 8 recipients
  5. Georgia $22,288 4% · 49 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

2,039 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record